Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$58.92 - $84.67 $7.98 Million - $11.5 Million
135,389 New
135,389 $8.38 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $370,004 - $542,237
-4,660 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$86.42 - $109.81 $402,717 - $511,714
4,660 New
4,660 $490,000
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $3.38 Million - $4.25 Million
-50,410 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $2.78 Million - $4.03 Million
50,410 New
50,410 $3.92 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.